More articles from Myelodysplastic Syndromes

Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki
Masataka Taguchi, Hiroyuki Mishima, Yusuke Shiozawa, Chisa Hayashida, Akira Kinoshita, Yasuhito Nannya, Hideki Makishima, Makiko Horai, Masatoshi Matsuo, Shinya Sato, Hidehiro Itonaga, Takeharu Kato, Hiroaki Taniguchi, Daisuke Imanishi, Yoshitaka Imaizumi, Tomoko Hata, Motoi Takenaka, Yukiyoshi Moriuchi, Yuichi Shiraishi, Satoru Miyano, Seishi Ogawa, Koh-ichiro Yoshiura, Yasushi Miyazaki

Haematologica Feb 2020, 105 (2) 358-365; DOI: 10.3324/haematol.2019.219386
Elevated TWIST1 expression in myelodysplastic syndromes/ acute myeloid leukemia reduces efficacy of hypomethylating therapy with decitabine
Hongjiao Li, Yi Wang, Xingchen Pang, Chenglian Xie, H. Joachim Deeg, Hui Wang, Ting Wan, Jinpeng Wu, Feng Guan, Xiang Li

Haematologica Jan 2020, haematol.2019.235325; DOI: 10.3324/haematol.2019.235325
Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis
Maximilian Stahl, Jan Philipp Bewersdorf, Smith Giri, Rong Wang, Amer M. Zeidan

Haematologica Jan 2020, 105 (1) 102-111; DOI: 10.3324/haematol.2019.219345
Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study
Tatiana Raskovalova, Marc G. Berger, Marie-Christine Jacob, Sophie Park, Lydia Campos, Carmen Mariana Aanei, Julie Kasprzak, Bruno Pereira, José Labarère, Jean-Yves Cesbron, Richard Veyrat-Masson

Haematologica Dec 2019, 104 (12) 2382-2390; DOI: 10.3324/haematol.2018.202275
Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma
Seiichiro Katagiri, Hideki Makishima, Kenko Azuma, Yasuhito Nannya, Yuu Saitoh, Seiichiro Yoshizawa, Daigo Akahane, Hiroaki Fujimoto, Yoshikazu Ito, Ravi Velaga, Tomohiro Umezu, Junko H. Ohyashiki, Seishi Ogawa, Kazuma Ohyashiki

Haematologica Nov 2019, haematol.2019.229856; DOI: 10.3324/haematol.2019.229856
Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a grey zone combination of myelodysplastic and myeloproliferative features?
Valentina FI Sangiorgio, Julia T Geyer, Elizabeth Margolskee, Mustafa Al- Kawaaz, Susan Mathew, Wayne Tam, Attilio Orazi

Haematologica Sep 2019, haematol.2019.227686; DOI: 10.3324/haematol.2019.227686
Synergistic effects of PRIMA-1Met (APR-246) and Azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Pierre Ly, Philippe Aubin, Nadia Naoui, Marie-Helene Schlageter, Cecile Bally, Elsa Miekoutima, Rami Rahmé, Jacqueline Lehmann-Che, Lionel Ades, Pierre Fenaux, Bruno Cassinat, Stephane Giraudier

Haematologica Sep 2019, haematol.2019.218453; DOI: 10.3324/haematol.2019.218453
5-Formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively
Daniel Gackowski, Maciej Gawronski, Cassandra Kerr, Tomas Radivoyevitch, Ewelina Zarakowska, Marta Starczak, Abdulkadir Abakir, Alexey Ruzov, Jaroslaw P. Maciejewski, Ryszard Olinski

Haematologica Sep 2019, haematol.2019.224030; DOI: 10.3324/haematol.2019.224030
Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with associated inflammatory state
Sihem Tarfi, Bouchra Badaoui, Nicolas Freynet, Margot Morabito, Jeffie Lafosse, Andréa Toma, Gabriel Etienne, Jean-Baptiste Micol, Ivan Sloma, Pierre Fenaux, Eric Solary, Dorothée Selimoglu-Buet, Orianne Wagner-Ballon, Groupe Francophone des Myelodysplasies (GFM)

Haematologica Aug 2019, haematol.2019.219782; DOI: 10.3324/haematol.2019.219782
Genomics of therapy-related myeloid neoplasms
Teodora Kuzmanovic, Bhumika J. Patel, Srinivasa R. Sanikommu, Yasunobu Nagata, Hassan Awada, Cassandra M. Kerr, Bartlomiej P. Przychodzen, Babal K. Jha, Devendra Hiwase, Deepak Singhal, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Sudipto Mukherjee, Jaroslaw P. Maciejewski, Tomas Radivoyevitch

Haematologica Aug 2019, haematol.2019.219352; DOI: 10.3324/haematol.2019.219352

More articles from Myelodysplastic Syndromes

Pages